1. Tortugas Neuroscience Launches with $106M, Targets Schizophrenia & Tinnitus with Drugs from China's Hansoh
A new biotech startup is betting that the next wave of treatments for complex brain disorders will come from Asia. Tortugas Neuroscience launched with $106 million in funding and a pipeline built on drugs licensed from major Chinese and Japanese pharmaceutical firms, signaling a strategic shift in sourcing neurological...